FINEPOINT CAPITAL LP Holdings

FINEPOINT CAPITAL LP is an investment fund managing more than 304.05M US dollars. The largest holdings include Travere Therapeutics, Algoma Steel Group and Prothena Corporation. In Q3 2022 the fund bought assets of total value of 70.79M US dollars and sold assets of total value of 65.62M US dollars.

$304.04M

portfolio value

+16.33%

quarter

+6.36%

1 year

+21.77%

3 years

+15.47%

5 years

FINEPOINT CAPITAL LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q3 2017	71831000	11923000
Q4 2017	121931000	34343000
Q1 2018	27963000	233895000
Q3 2018	-122311228	19954000
Q1 2019	146287000	50345000
Q3 2019	143294000	130331000
Q4 2020	2507000	83083000
Q3 2021	220069000	210901000
Q4 2021	43443000	184824000
Q1 2022	51541000	134232000
Q2 2022	250356000	247988000
Q3 2022	70786000	65623000

FINEPOINT CAPITAL LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Travere Therapeutics, Inc. Portfolio share: 8.34% Portfolio value: 25.35M Avg. open price: $24.23 Current price: $20.01 P/L: -17.42% Bought +76.09% shares Q3 2022	share	8.34%	25.35M	$24.23	$20.01	-17.42%	Bought +76.09% shares Q3 2022
Steel Algoma Steel Group Inc. Portfolio share: 7.87% Portfolio value: 23.93M Avg. open price: N/A Current price: $6.55 P/L: N/A N/A Q1 2022	share	7.87%	23.93M	N/A	$6.55	N/A	N/A Q1 2022
Biotechnology Prothena Corporation plc Portfolio share: 6.09% Portfolio value: 18.51M Avg. open price: N/A Current price: $60.39 P/L: N/A Sold -33.25% shares Q3 2022	share	6.09%	18.51M	N/A	$60.39	N/A	Sold -33.25% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 6.07% Portfolio value: 18.44M Avg. open price: N/A Current price: $38.12 P/L: N/A Sold -9.21% shares Q3 2022	share	6.07%	18.44M	N/A	$38.12	N/A	Sold -9.21% shares Q3 2022
Biotechnology ACADIA Pharmaceuticals Inc. Portfolio share: 5.98% Portfolio value: 18.17M Avg. open price: $14.09 Current price: $15.24 P/L: +8.16% Bought +57.10% shares Q3 2022	share	5.98%	18.17M	$14.09	$15.24	+8.16%	Bought +57.10% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 5.98% Portfolio value: 18.17M Avg. open price: N/A Current price: $49.41 P/L: N/A Sold -16.43% shares Q3 2022	share	5.98%	18.17M	N/A	$49.41	N/A	Sold -16.43% shares Q3 2022
Biotechnology Arvinas, Inc. Portfolio share: 5.84% Portfolio value: 17.75M Avg. open price: N/A Current price: $39.53 P/L: N/A N/A Q3 2022	share	5.84%	17.75M	N/A	$39.53	N/A	N/A Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 5.83% Portfolio value: 17.71M Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q2 2022	share	5.83%	17.71M	N/A	$21.89	N/A	N/A Q2 2022
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 5.80% Portfolio value: 17.62M Avg. open price: N/A Current price: $12.37 P/L: N/A Sold -16.04% shares Q3 2022	share	5.80%	17.62M	N/A	$12.37	N/A	Sold -16.04% shares Q3 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 5.56% Portfolio value: 16.91M Avg. open price: $25.34 Current price: $33.96 P/L: +34.02% Bought +20.86% shares Q3 2022	share	5.56%	16.91M	$25.34	$33.96	+34.02%	Bought +20.86% shares Q3 2022
Biotechnology Sage Therapeutics, Inc. Portfolio share: 5.53% Portfolio value: 16.81M Avg. open price: N/A Current price: $43.52 P/L: N/A Sold -9.73% shares Q3 2022	share	5.53%	16.81M	N/A	$43.52	N/A	Sold -9.73% shares Q3 2022
Biotechnology Galapagos NV Portfolio share: 5.32% Portfolio value: 16.19M Avg. open price: $55.8 Current price: $38.92 P/L: -30.25% Bought +46.38% shares Q3 2022	share	5.32%	16.19M	$55.8	$38.92	-30.25%	Bought +46.38% shares Q3 2022
Biotechnology Iovance Biotherapeutics, Inc. Portfolio share: 5.00% Portfolio value: 15.19M Avg. open price: $11.04 Current price: $8.03 P/L: -27.26% Bought +65.18% shares Q3 2022	share	5.00%	15.19M	$11.04	$8.03	-27.26%	Bought +65.18% shares Q3 2022
Biotechnology Cerevel Therapeutics Holdings, Inc. Portfolio share: 4.99% Portfolio value: 15.17M Avg. open price: N/A Current price: $28.31 P/L: N/A N/A Q3 2022	share	4.99%	15.17M	N/A	$28.31	N/A	N/A Q3 2022
DISH NETWORK CORPORATION Portfolio share: 4.35% Portfolio value: 13.22M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	4.35%	13.22M	N/A	N/A	N/A	N/A Q3 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 4.19% Portfolio value: 12.74M Avg. open price: N/A Current price: $119.41 P/L: N/A Sold -22.63% shares Q3 2022	share	4.19%	12.74M	N/A	$119.41	N/A	Sold -22.63% shares Q3 2022
Biotechnology argenx SE Portfolio share: 3.34% Portfolio value: 10.15M Avg. open price: N/A Current price: $393.21 P/L: N/A Sold -45.51% shares Q3 2022	share	3.34%	10.15M	N/A	$393.21	N/A	Sold -45.51% shares Q3 2022
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 2.89% Portfolio value: 8.79M Avg. open price: N/A Current price: $24.25 P/L: N/A N/A Q3 2022	share	2.89%	8.79M	N/A	$24.25	N/A	N/A Q3 2022
GLOBAL BUSINESS TRAVEL GROUP Portfolio share: 0.47% Portfolio value: 1.43M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.47%	1.43M	N/A	N/A	N/A	N/A Q2 2022
BRIDGETOWN HOLDINGS LTD Portfolio share: 0.04% Portfolio value: 116K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.04%	116K	N/A	N/A	N/A	N/A Q3 2021
ZIMMER ENERGY TRANSITION ACQUISITION CORP Portfolio share: 0.04% Portfolio value: 111K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.04%	111K	N/A	N/A	N/A	N/A Q4 2021
Shell Companies Conyers Park III Acquisition Corp. Portfolio share: 0.03% Portfolio value: 104K Avg. open price: N/A Current price: $0.18 P/L: N/A N/A Q4 2021	share	0.03%	104K	N/A	$0.18	N/A	N/A Q4 2021
STARRY GROUP HOLDINGS INC Portfolio share: 0.03% Portfolio value: 87K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	0.03%	87K	N/A	N/A	N/A	N/A Q1 2022
CONCORD ACQUISITION CORP II Portfolio share: 0.03% Portfolio value: 86K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.03%	86K	N/A	N/A	N/A	N/A Q4 2021
CHURCHILL CAPITAL CORP VI Portfolio share: 0.03% Portfolio value: 76K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.03%	76K	N/A	N/A	N/A	N/A Q3 2021
CHURCHILL CAPITAL CORP VII Portfolio share: 0.02% Portfolio value: 74K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.02%	74K	N/A	N/A	N/A	N/A Q3 2021
SUMMIT HEALTHCARE ACQUISITION CORP Portfolio share: 0.02% Portfolio value: 74K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.02%	74K	N/A	N/A	N/A	N/A Q3 2021
Gores Technology Partners II, Inc. Portfolio share: 0.02% Portfolio value: 72K Avg. open price: N/A Current price: $0 P/L: N/A N/A Q3 2021	share	0.02%	72K	N/A	$0	N/A	N/A Q3 2021
KKR ACQUISITION HOLDINGS I CORP Portfolio share: 0.02% Portfolio value: 71K Avg. open price: N/A Current price: N/A P/L: N/A Bought +28.18% shares Q3 2021	share	0.02%	71K	N/A	N/A	N/A	Bought +28.18% shares Q3 2021
JAWS HURRICANE ACQUISITION CORP Portfolio share: 0.02% Portfolio value: 65K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.02%	65K	N/A	N/A	N/A	N/A Q3 2021
AFTERNEXT HEALTHTECH ACQUISITION CORP Portfolio share: 0.02% Portfolio value: 59K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.02%	59K	N/A	N/A	N/A	N/A Q4 2021
ARES ACQUISITION CORP Portfolio share: 0.02% Portfolio value: 58K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.02%	58K	N/A	N/A	N/A	N/A Q3 2021
FORTRESS VALUE ACQUISITION COR Portfolio share: 0.02% Portfolio value: 54K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.02%	54K	N/A	N/A	N/A	N/A Q3 2021
CHURCHILL CAPITAL CORP V Portfolio share: 0.02% Portfolio value: 52K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.02%	52K	N/A	N/A	N/A	N/A Q3 2021
BERENSON ACQUISITION CORP I Portfolio share: 0.01% Portfolio value: 44K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.01%	44K	N/A	N/A	N/A	N/A Q4 2021
SKYDECK ACQUISITION CORP Portfolio share: 0.01% Portfolio value: 42K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	42K	N/A	N/A	N/A	N/A Q3 2021
COMPASS DIGITAL ACQUISITION CORP Portfolio share: 0.01% Portfolio value: 41K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.01%	41K	N/A	N/A	N/A	N/A Q4 2021
Gores Technology Partners, Inc. Portfolio share: 0.01% Portfolio value: 38K Avg. open price: N/A Current price: $0 P/L: N/A N/A Q3 2021	share	0.01%	38K	N/A	$0	N/A	N/A Q3 2021
FIRST LIGHT ACQUISITION GROUP INC Portfolio share: 0.01% Portfolio value: 37K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.01%	37K	N/A	N/A	N/A	N/A Q4 2021
CATALYST PARTNERS ACQUISITION Portfolio share: 0.01% Portfolio value: 37K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	37K	N/A	N/A	N/A	N/A Q3 2021
BILANDER ACQUISITION CORP Portfolio share: 0.01% Portfolio value: 36K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	36K	N/A	N/A	N/A	N/A Q3 2021
ROSS ACQUISITION CORP II Portfolio share: 0.01% Portfolio value: 34K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	34K	N/A	N/A	N/A	N/A Q3 2021
FORTRESS CAPITAL ACQUISITION C Portfolio share: 0.01% Portfolio value: 31K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	31K	N/A	N/A	N/A	N/A Q3 2021
CORSAIR PARTNERING CORP Portfolio share: 0.01% Portfolio value: 28K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	28K	N/A	N/A	N/A	N/A Q3 2021
Shell Companies Swiftmerge Acquisition Corp. Portfolio share: 0.01% Portfolio value: 25K Avg. open price: N/A Current price: $0.03 P/L: N/A N/A Q1 2022	share	0.01%	25K	N/A	$0.03	N/A	N/A Q1 2022
FORTRESS VALUE ACQUISITION COR Portfolio share: 0.01% Portfolio value: 23K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	23K	N/A	N/A	N/A	N/A Q3 2021
SIMON PROPERTY GROUP ACQUISITION HOLDINGS INC Portfolio share: 0.01% Portfolio value: 22K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	22K	N/A	N/A	N/A	N/A Q3 2021
COHN ROBBINS HOLDINGS CORP Portfolio share: 0.01% Portfolio value: 21K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	21K	N/A	N/A	N/A	N/A Q3 2021
HEALTH ASSURANCE ACQUISITION C Portfolio share: 0.01% Portfolio value: 19K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	19K	N/A	N/A	N/A	N/A Q3 2021
Revolution Healthcare Acquisition Corp. Portfolio share: 0.01% Portfolio value: 17K Avg. open price: N/A Current price: $0 P/L: N/A N/A Q3 2021	share	0.01%	17K	N/A	$0	N/A	N/A Q3 2021
Shell Companies Home Plate Acquisition Corporation Portfolio share: 0.01% Portfolio value: 17K Avg. open price: N/A Current price: $0 P/L: N/A N/A Q4 2021	share	0.01%	17K	N/A	$0	N/A	N/A Q4 2021
Shell Companies Marblegate Acquisition Corp. Portfolio share: 0.01% Portfolio value: 16K Avg. open price: N/A Current price: $0.05 P/L: N/A N/A Q4 2021	share	0.01%	16K	N/A	$0.05	N/A	N/A Q4 2021
Levere Holdings Corp. Portfolio share: 0.00% Portfolio value: 14K Avg. open price: N/A Current price: $0.01 P/L: N/A N/A Q3 2021	share	0.00%	14K	N/A	$0.01	N/A	N/A Q3 2021
Senior Connect Acquisition Corp. I Portfolio share: 0.00% Portfolio value: 10K Avg. open price: N/A Current price: $0.03 P/L: N/A N/A Q3 2021	share	0.00%	10K	N/A	$0.03	N/A	N/A Q3 2021
WARBURG PINCUS CAPITAL CORP I-B Portfolio share: 0.00% Portfolio value: 8K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	8K	N/A	N/A	N/A	N/A Q3 2021
MUSIC ACQUISITION CORP/THE Portfolio share: 0.00% Portfolio value: 3K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	3K	N/A	N/A	N/A	N/A Q3 2021
WARBURG PINCUS CAPITAL CORP I-A Portfolio share: 0.00% Portfolio value: 1K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	1K	N/A	N/A	N/A	N/A Q3 2021
Biotechnology Global Blood Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $68.49 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$68.49	N/A	Sold -100.00% shares Q3 2022
Social Capital Hedosophia Holdings Corp VI Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Equity Distribution Acquisitio Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $92.75 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$92.75	N/A	Sold -100.00% shares Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $122.96 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$122.96	N/A	Sold -100.00% shares Q3 2022
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.8 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.8	N/A	Sold -100.00% shares Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $39.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$39.83	N/A	Sold -100.00% shares Q3 2022

Showing TOP 64 FINEPOINT CAPITAL LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of FINEPOINT CAPITAL LP?

The biggest position of the FINEPOINT CAPITAL LP is Travere Therapeutics, Inc. (TVTX) with 8.34% portfolio share worth of 25.35M US dollars.

Top 5 FINEPOINT CAPITAL LP's holdings represent 34.35% of the portfolio:

Travere Therapeutics, Inc. (TVTX) – 8.34%
Algoma Steel Group Inc. (ASTL) – 7.87%
Prothena Corporation plc (PRTA) – 6.09%
Cytokinetics, Incorporated (CYTK) – 6.07%
ACADIA Pharmaceuticals Inc. (ACAD) – 5.98%

Who is the portfolio manager of FINEPOINT CAPITAL LP?

The portfolio manager of the FINEPOINT CAPITAL LP is .

What is the total asset value of the FINEPOINT CAPITAL LP portfolio?

FINEPOINT CAPITAL LP total asset value (portfolio value) is 304.05M US dollars.

Who is ?

is the portfolio manager of the FINEPOINT CAPITAL LP.

What is (FINEPOINT CAPITAL LP) fund performance?

FINEPOINT CAPITAL LP's quarterly performance is +16.33%, annualy +6.36%. In the past 3 years, the value of 's portfolio has increased by +22%. In the past 5 years, the value of the portfolio has increased by +15%.

What is the FINEPOINT CAPITAL LP CIK?

FINEPOINT CAPITAL LP's Central Index Key is 0001608126 .

FINEPOINT CAPITAL LP Holdings

FINEPOINT CAPITAL LP portfolio value:

FINEPOINT CAPITAL LP quarter portfolio value change:

FINEPOINT CAPITAL LP 1 year portfolio value change:

FINEPOINT CAPITAL LP 3 years portfolio value change:

FINEPOINT CAPITAL LP 5 years portfolio value change: